{
    "case_number": "CAC-UDRP-101882",
    "time_of_filling": "2018-02-21 09:50:37",
    "domain_names": [
        "kymriahcares.com"
    ],
    "case_administrator": "  Iveta Špiclová   (Czech Arbitration Court) (Case admin)",
    "complainant": [
        "Novartis AG"
    ],
    "complainant_representative": "BrandIT GmbH",
    "respondent": [
        "chen ki"
    ],
    "respondent_representative": null,
    "factual_background": "FACTS ASSERTED BY THE COMPLAINANT AND NOT CONTESTED BY THE RESPONDENT:\r\n\r\n \r\nThe Complainant is the producer of the immunotherapy KYMRIAH. It is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. The Complainant’s products are available in more than 180 countries and they reached nearly 1 billion people globally in 2015. About 123,000 people of 144 nationalities work at Novartis around the world. KYMRIAH is a novel immunotherapy to fight cancer and has received prominent media coverage online. In more detail, KYMRIAH is a CD19-directed genetically-modified autologous T cell immunotherapy indicated for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.\r\n\r\nThe Complainant owns trademark registrations for the marks KYMRIAH and KYMRIAH CARES as below (IR = International Registration):\r\n\r\nTM: KYMRIAH \r\nReg. no. IR1212288\r\nClass: 05; 44 \r\nDate of Registration: 06.06.2014 (inc. Singapore)\r\n\r\nSingaporean TM: Kymriah\r\nReg. no. T1412840H \r\nClass: 05; 44 \r\nDate of Registration: 06.06.2014\r\n\r\nTM: KYMRIAH CARES \r\nReg. no. IR1366728\r\nClass: 44 \r\nDate of registration: 11.07.2017 \r\n\r\nSwiss TM: KYMRIAH CARES \r\nReg. no. 704618 \r\nClass: 44 \r\nDate of application: 11.05.2017\r\nDate of registration: 11.07.2017\r\n\r\nThe disputed domain name was registered on May 23, 2017.\r\n",
    "other_legal_proceedings": "The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.",
    "no_response_filed": "NO ADMINISTRATIVELY COMPLIANT RESPONSE HAS BEEN FILED.",
    "rights": "The Complainant has, to the satisfaction of the Panel, shown the disputed domain name  to be identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).",
    "no_rights_or_legitimate_interests": "The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).",
    "bad_faith": "The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).",
    "procedural_factors": "The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.",
    "decision": "Accepted",
    "panelists": [
        "Mr. Ho-Hyun Nahm, Esq."
    ],
    "date_of_panel_decision": "2018-04-06 00:00:00",
    "informal_english_translation": "The Complainant owns trademark registrations for the marks KYMRIAH and KYMRIAH CARES as below (IR = International Registration):\r\n\r\nTM: KYMRIAH \r\nReg. no. IR1212288\r\nClass: 05; 44 \r\nDate of Registration: 06.06.2014 (inc. Singapore)\r\n\r\nSingaporean TM: Kymriah\r\nReg. no. T1412840H \r\nClass: 05; 44 \r\nDate of Registration: 06.06.2014\r\n\r\nTM: KYMRIAH CARES \r\nReg. no. IR1366728\r\nClass: 44 \r\nDate of registration: 11.07.2017 \r\n\r\nSwiss TM: KYMRIAH CARES \r\nReg. no. 704618 \r\nClass: 44 \r\nDate of application: 11.05.2017\r\nDate of registration: 11.07.2017\r\n",
    "decision_domains": {
        "KYMRIAHCARES.COM": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}